Aurobindo Pharma rose 3.08% to Rs 633.95 at 11:02 IST on BSE as the stock will be included in the MSCI India index effective from the close of trade on 30 May 2014.
Meanwhile, the BSE Sensex was up 29.53 points, or 0.12%, to 23,844.65.
On BSE, so far 1.57 lakh shares were traded in the counter, compared with an average volume of 3.53 lakh shares in the past one quarter.
The stock hit a high of Rs 635 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 618.60 so far during the day. The stock hit a 52-week low of Rs 138.45 on 6 August 2013.
The stock had outperformed the market over the past one month till 14 May 2014, rising 11.84% compared with 5.24% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 25.41% as against Sensex's 16.93% rise.
The large-cap company has an equity capital of Rs 29.15 crore. Face value per share is Re 1.
More From This Section
In a rejig of its indices, MSCI, a leading provider of benchmark indices globally, has added Aurobindo Pharma to the MSCI India index after its semi-annual global index review.
The index provider also added 13 stocks and deleted the same number from MSCI global small-cap indexes.
Changes will be implemented from the close of trade on 30 May 2014.
On a consolidated basis, Aurobindo Pharma's net profit jumped 354.7% to Rs 417.49 crore on 37.6% growth in net sales to Rs 2135.52 crore in Q3 December 2013 over Q3 December 2012.
Aurobindo Pharma, headquartered at Hyderabad, manufactures generic pharmaceuticals and active pharmaceutical ingredients (APIs). The company's manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil. The company's robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up. The company is marketing these products globally, in over 125 countries.
Powered by Capital Market - Live News